Dismissal Of Investor Suit Against Hepatitis B Drug Maker Upheld On Appeal
SAN FRANCISCO — A lead plaintiff in a securities class action lawsuit against a drug company and three of its senior executives has failed to plead falsity and scienter in making...To view the full article, register now.
Already a subscriber? Click here to view full article